Sotuvning operatsion marjasi: Theriva Biologics Inc (TOVX)

Theriva Corp (TOVX) kompaniyasining korporativ logotipi

Gastrointestinal trakt uchun onkolitik viruslarning rivojlanish dinamikasi GURU.Markets tizimi operatsion daromad stavkasini qanday hisoblashiga o'xshashdir, bunda -3256.00 qiymati joriy ko'rsatkich vazifasini o'taydi. Takrorlanishlarga qarshi kurashish uchun terapiyaning jarrohlik bilan integratsiyasi ushbu vektorni to'ldiradi, onkologiya markazlaridagi yuqori kechiktirilgan talab esa platformaning potentsialini tasdiqlab, qarz xizmati xarajatlarining Theriva Biologics, Inc. (TOVX) balansiga ta'sirini aks ettiradi.

TOVX: therivabio.com Operatsion foyda normasi 28.04.2023 - 20.11.2026

Theriva Biologics, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (TOVX)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:TOVX, Theriva Biologics
Theriva Corp asosiy tovari

Operatsion marja tushumlar ichidagi asosiy faoliyatdan olingan foyda ulushini aks ettiradi va moliyaviy majburiyatlar hisobga olinishidan oldin xarajatlarni nazorat qilish hamda pul oqimini yaratish bo'yicha rahbariyatning qobiliyatini namoyish etadi. Operatsion rentabellik tendentsiyalarini tahlil qilish orqali investor Theriva Biologics, Inc. (TOVX) kompaniyasining biznesni kengaytirish samaradorligini baholaydi, bunda robotlashtirilgan laboratoriyalarning joriy etilishi yuqori xarajatli xodimlarga bo'lgan bog'liqlikni kamaytirishi va ishlab chiqarish xarajatlarini optimallashtirishi kutilmoqda.

Theriva Biologics, Inc. kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Compass Therapeutics - Operatsion foyda normasi|REPL (replimune.com) - Operatsion marja|Operatsion marja Lyell|Operatsion rentabellik Innate Pharma (IPHA)|PYXS: Operatsion foyda marjasi|Compugen - Sotuvning operatsion marjasi|IO Biotech, Inc. (IOBT) - Sotuvning operatsion rentabelligi|STRO - Operatsion rentabellik|MiNK Therapeutics (INKT) - Sotuvning operatsion marjasi|HOWL: Operatsion marja|Sotuvning operatsion marjasi Immix|Sotuvning operatsion marjasi ALXO|CUE: Operatsion foyda normasi|Sotuvning operatsion marjasi PDSB (PDS Biotech)|Sonnet BioTherapeutics Holdings - Operatsion foyda bo'yicha sotuv rentabelligi|MAIA Biotechnology Inc - Sotuvning operatsion marjasi|LIMN: Operatsion foyda bo'yicha sotuv rentabelligi|LVTX: Sotuvning operatsion marjasi|NXTC - Operatsion marja|LPTX: Operatsion marja|INTS - Operatsion faoliyat rentabelligi|SNSE (Sensei Biotherapeutics) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja